|
Platelet function inhibitors
Citations 211-220 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Correspondence
Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization Response
- Kausik K. Ray, A. Michael Lincoff, Eric J. Topol, Dean J. Kereiakes, Mary A. Mascelli, Lawrence I. Deckelbaum, Elliot S. Barnathan, Kamlesh K. Patel, Bart Frederick, and Marian T. Nakada
Circulation 2002;105:e74, doi:10.1161/01.CIR.0000012243.75725.3B
[Full text]
- Articles
Aspirin-Resistant Thromboxane
Biosynthesis and the Risk of Myocardial Infarction, Stroke, or
Cardiovascular Death in Patients at High Risk for
Cardiovascular Events
- John W. Eikelboom, Jack Hirsh, Jeffrey I. Weitz, Marilyn Johnston, Qilong Yi, and Salim Yusuf
Circulation published March 25, 2002, doi:10.1161/01.CIR.0000013777.21160.07
[Abstract]
- Clinician Update
Oral Anticoagulation for Acute Coronary Syndromes
- Marc A. Brouwer and Freek W.A. Verheugt
Circulation 2002;105:1270-1274, doi:10.1161/hc1102.105594
[Full text]
- Clinical Investigations and Reports
Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein IIbß3 (GPIIb/IIIa) and vß3 Receptors Are Not Protected From Atherosclerosis
- O. Shpilberg, I. Rabi, K. Schiller, R. Walden, D. Harats, K.S. Tyrrell, B. Coller, and U. Seligsohn
Circulation 2002;105:1044-1048; published online before print as doi:10.1161/hc0902.104676
[Abstract]
[Full text]
- Correspondence
Synergism Among Flavonoids in Inhibiting Platelet Aggregation and H2O2 Production Response
- F. Violi, P. Pignatelli, F.M. Pulcinelli, Jane E. Freedman, Crawford Parker, III, Liqing Li, Jacob A. Perlman, Balz Frei, Vadim Ivanov, Leslie R. Deak, Mark D. Iafrati, and John D. Folts
Circulation 2002;105:e53
[Full text]
- Articles
Patients With Glanzmann Thrombasthenia
Lacking Platelet Glycoprotein
IIbß3 (GPIIb/IIIa)
and vß3 Receptors
Are Not Protected From Atherosclerosis
- O. Shpilberg, I. Rabi, K. Schiller, R. Walden, D. Harats, K. S. Tyrrell, B. Coller, and U. Seligsohn
Circulation published February 11, 2002, doi:10.1161/hc0902.104676
[Abstract]
- Clinical Investigations and Reports
Department of Veterans Affairs Cooperative Studies Program Clinical Trial Comparing Combined Warfarin and Aspirin With Aspirin Alone in Survivors of Acute Myocardial Infarction: Primary Results of the CHAMP Study
- Louis D. Fiore, Michael D. Ezekowitz, Mary T. Brophy, David Lu, Joseph Sacco, and Peter Peduzzi
Circulation 2002;105:557-563, doi:10.1161/hc0502.103329
[Abstract]
[Full text]
- Clinical Investigations and Reports
Randomized, Placebo-Controlled Trial of Titrated Intravenous Lamifiban for Acute Coronary Syndromes
-
Circulation 2002;105:316-321, doi:10.1161/hc0302.102573
[Abstract]
[Full text]
- Clinical Investigations and Reports
Outcomes of Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting: Results From the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial
- Marino Labinaz, Rakhi Kilaru, Karen Pieper, Steven P. Marso, Michael M. Kitt, Maarten L. Simoons, Robert M. Califf, Eric J. Topol, Paul W. Armstrong, and Robert A. Harrington
Circulation 2002;105:322-327, doi:10.1161/hc0302.102578
[Abstract]
[Full text]
- Correspondence
Platelet Inhibition After Glycoprotein IIb/IIIa Inhibitor Therapy
- Michele Galli
Circulation 2001;104:e163
[Full text]
|
|